Platelet-boosting medicine for low platelets during cancer treatment
Treatments studied
Part of Blood & lymphatic, Cancer clinical trials.
This study tests a new version of a platelet-boosting medicine (romiplostim) for people whose platelets drop during cancer treatment. The goal is to see if it can safely raise platelet counts so you can continue your therapy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old
- You have a confirmed diagnosis of a solid tumor (not a blood cancer)
- You are currently receiving chemotherapy or radiation therapy, with or without immunotherapy
- Your platelet count is between 25 and 75 x 10^9/L (very low, but not dangerously low)
- Your doctor expects you to live for at least 3 more months and you can complete at least 2 more cycles of chemo
- You have not taken certain platelet-raising drugs before (like romiplostim or eltrombopag)
- You have not had a blood clot, heart problem, or platelet transfusion recently
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a drug called romiplostim to help your body make platelets faster after a stem cell transplant. Platelets help your blood clot, and getting them back sooner can reduce bleeding risks and speed recovery.
This trial tests if combining two platelet-raising drugs (TPO and a TPO receptor agent) can help patients with solid tumors who have very low platelets after cancer treatment. It aims to prevent or treat severe platelet drops.
This trial tests if a new drug called Romiplostim N01 works better than the standard drug Interleukin-11 for raising low platelet counts caused by cancer treatments like chemotherapy or radiation. If you have low platelets from your cancer therapy, you may be able to join.
This trial tests a drug called romiplostim for patients whose platelet counts stay very low (below 30) for a long time after chemotherapy, even after other treatments have failed. The goal is to see if romiplostim can help raise your platelet count to a safer level.
This study tests a new medication called romiplostim that may help raise your platelet count when it drops too low after radiation therapy. If you have a solid tumor and your platelets are below 75,000, this treatment could help you recover and avoid complications.
This trial tests a new version of a drug called romiplostim to help raise platelet counts in breast cancer patients whose platelets drop because of chemotherapy. Raising your platelets may reduce the risk of bleeding and allow you to continue your cancer treatment.
Hear when a new CTIT-Chemotherapy Induced Thrombocytopenia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.